Med Op-Ed: Time Toxicity, Clinical Trial Access, and RECIST Edited by Victoria Stern

https://www.medscape.com/viewarticle/med-op-ed-time-toxicity-clinical-trial-access-and-recist-2026a10013hh In this installment of Med Op-Ed: The concept of time toxicity is morphing from patient- to stakeholder-centric, clinical trial access remains a challenge, and why it’s time to revisit Response Evaluation Criteria in Solid Tumors (RECIST).